PNW — Pinnacle West Capital Corporation

As of 2026-09-13 the tape and the sell side disagree mildly, which is why sentiment is best described as neutral rather than bullish or bearish. The August 4, 2026 Q2 print showed revenue up 7.1% YoY to $1.46B (beating ~$1.40B consensus) but EPS falling to $1.43 from $1.58, and management reaffirmed FY2026 guidance of $4.55-$4.75 - a number that is roughly 8% below FY2025's $5.05 of actual quarterly-summed EPS. Sell-side positioning reflects that ambivalence: the consensus rating is Hold (7 Buy, 17 Hold, 1 Sell), with a consensus target of $106.86 but a more recent average of $104, and Morgan Stanley anchoring the low end at $94-$97 versus Barclays near $108. The brief notes PNW has outperformed the XLU ETF year-to-date on Arizona's economic expansion, yet the shares are -4.28% over one month and -6.62% over six, and an RSI of 31.87 shows the market has been quietly de-rating the stock even as the fundamental story (2.2%-2.4% customer growth, 4%-6% targeted sales growth) stays intact.

There are two trends running in opposite directions, and that is the single most important thing to understand about PNW right now. The top line is genuinely accelerating: revenue grew 11.4% YoY in Q1 2026 ($1,149.6M vs $1,032.3M) and 7.1% YoY in Q2 2026 ($1,455.7M vs $1,358.8M), versus roughly 3% YoY growth in mid-2025 (Q3 2025 +2.9%, Q4 2025 +3.0%). That inflection is real and driven by Arizona customer additions and early-summer cooling load, not by one-off items. The bottom line is going the other way. Q2 2026 operating income was essentially flat YoY ($305.7M vs $307.6M), which means operating margin actually compressed to 21.0% from 22.6%, and net income fell to $178.6M from $192.6M. Q1 2026 is the clearest illustration of the squeeze: $401.4M of operating income converted into only $32.9M of net income. Summing the four reported quarters gives FY2025 EPS of $5.05 (-0.04, +1.58, +3.39, +0.12) against FY2026 guidance of $4.55-$4.75 - a deliberate ~8% earnings decline. The cause is not operational deterioration; it is higher interest expense and higher depreciation/amortization on a rate base that is being built now but recovered through rates later. Trailing-twelve-month revenue is $5,554M with TTM net income of $640M (11.5% net margin). Note also the extreme seasonality: Q3 alone produced $3.39 of EPS in 2025, so the late-October/early-November Q3 2026 print will effectively determine the full year.

As of 2026-09-13, PNW's $96.11 price equates to 18.07x TTM EPS of $5.277, against a five-year average P/E of 16.0x - a 13% premium to its own history - and 2.10x TTM sales versus a 1.94x five-year average. On forward numbers the picture looks worse, because earnings are declining: FY2026 guidance midpoint of $4.65 puts the stock at 20.7x, and the FMP next-FY estimate of $4.716 puts it at 20.4x. The PEG ratio of 2.65 is a clear signal that you are paying a lot per unit of growth. Price/book of 1.66x is unremarkable for a regulated utility, but it comes with an 8.7% ROE that sits below a typical allowed ROE of roughly 9.5%-10%, so there is no strong case for a premium book multiple either. The 3.61% dividend yield is the one valuation support, and it is roughly in line with the utility sector rather than a discount. Verdict: fair to slightly expensive, not cheap. The deterministic screen's 'Neutral vs. its own history' label is the right call, and I would lean toward the top half of that neutral range.

The stock is capitalizing a growth inflection that has not yet reached the earnings line. At 20.4x forward EPS versus a 16.0x five-year average, the market is paying today for 2027-2029 rate-base-driven earnings that depend on two things not yet delivered: a constructive Arizona Corporation Commission rate-case outcome, and data-center/semiconductor load converting from announced to contracted and energized. Meanwhile FY2026 EPS is guided down ~8%. That is a classic setup where the multiple does the work ahead of the earnings, and it cuts both ways. If the ACC delivers a fair allowed ROE and capital recovery and load growth materializes, 20x is defensible and the shares grind higher on the 2027-2028 EPS ramp. If rate-case outcomes lag or interest expense keeps eating the operating gains (Q1 2026 being the template), the multiple compresses toward 17x, which on $4.70-$4.85 of forward EPS implies $80-$85 - roughly 12%-18% downside. The lag between reported revenue beats and reported EPS misses is the tell, and it is worth watching whether the spread narrows in the Q3 2026 report.

As of 2026-09-13, the technical picture is a clean downtrend with an oversold tilt, not a bottom. RSI(14) stood at 31.87 - near oversold but not at the sub-30 extreme that historically marks capitulation - and price sat 2.13% below the 20-day SMA, 5.86% below the 50-day SMA, and 2.60% below the 200-day SMA. Being below all three simultaneously means there is no trend support at any timeframe. Trailing returns were -1.46% over one week, -4.28% over one month, -7.10% over three months, and -6.62% over six months, so the selling is persistent rather than a single shock. Against a 52-week range of $85.32-$111.16, the stock is 13.5% below its high and 12.6% above its low - squarely mid-range, which is the worst place to be for entry timing because there is neither a valuation floor nor momentum. An RSI near 30 combined with a stretched distance below the 50-day often precedes a technical bounce, but the disciplined approach is to wait for either a reclaim of the 50-day or a bullish RSI divergence, rather than buying simply because the stock looks 'oversold.'

• Interest rates and cost of capital are the dominant swing factor. PNW carries $9.776B of long-term debt and only $9.1M of cash, so every 25bp on refinancing costs flows almost directly to the bottom line - Q1 2026's $401.4M of operating income collapsing to $32.9M of net income is the math in action. Fed easing is a direct EPS tailwind; a re-steepening of the long end is the opposite.
• Arizona Corporation Commission regulatory cycle. The allowed ROE and the timing of capital recovery in pending APS rate cases set the earnings baseline more than any operating metric. An 8.7% earned ROE against a roughly 9.5%-10% allowed ROE is textbook regulatory lag, and it is the single biggest lever on forward earnings.
• The Arizona economic and demographic boom is the structural differentiator. Customer growth of 2.2%-2.4% and targeted long-term sales growth of 4%-6% from data centers, semiconductors and manufacturing put PNW in a different growth cohort than utilities in stagnant jurisdictions - and it is the reason the shares have beaten XLU year-to-date in 2026.
• Capital intensity and financing. Capex was $728.7M in Q2 2026 alone (~$2.65B TTM) against operating cash flow of $394.0M, producing -$334.7M of free cash flow in the quarter and roughly -$2.34B cumulative over twelve quarters. That funds through debt and equity issuance, meaning ongoing share-count creep and continued rate sensitivity.
• Bond-proxy rotation with a beta of 0.437. PNW's absolute performance is heavily tied to the 10-year Treasury and to demand for defensive dividend payers, so sector rotation out of utilities can pressure the stock even when company-specific news is fine - as appears to be happening in the -4.28% one-month move.

• Q3 2026 earnings in late October/early November 2026 - the peak summer cooling-load quarter that produced $3.39 of the $5.05 in FY2025 EPS. This print effectively decides whether management can hold the $4.55-$4.75 guidance range.
• Arizona Corporation Commission rulings and rate-case schedule developments. A constructive order on allowed ROE and capital recovery would reset the earnings baseline upward and is the single most significant valuation catalyst for the stock.
• Conversion of announced data-center and semiconductor load (TSMC, Intel, hyperscaler campuses) into signed, credit-backed contracts, including execution under APS CEO Ted Geisler's August 19, 2026 'Pledge for Responsible Energy Growth' framework requiring large customers to fully fund their grid infrastructure.
• The interest-rate path. Any sustained move lower in long yields directly relieves the interest drag that turned $401.4M of Q1 2026 operating income into $32.9M of net income, and simultaneously makes the 3.61% yield more competitive.
• A multiple re-rating toward the utility peer group if PNW can string together 7%+ revenue growth into 2027 while narrowing the revenue-to-EPS gap.

• Regulatory lag or an adverse ACC rate-case outcome. An earned ROE of 8.7% is already below the allowed range; a punitive order caps any EPS recovery regardless of how strong Arizona load growth is, and would likely force a consensus target reset toward Morgan Stanley's $94-$97.
• Interest expense and rising depreciation from a growing rate base. This is already the reason Q2 2026 EPS fell to $1.43 from $1.58 despite revenue rising 7.1%, and it is the reason FY2026 guidance implies an ~8% EPS decline versus FY2025's $5.05.
• Balance-sheet leverage and liquidity. Debt-to-equity of 1.62x, $9.776B of long-term debt, a 0.594 current ratio, and $9.1M of cash against $3.37B of current liabilities leave very little buffer and make the company dependent on continuous capital-markets access at reasonable rates.
• Dividend coverage strain. The $3.47 annual payout against FY2026 guidance of $4.65 (midpoint) is roughly a 75% payout ratio - high for a utility, and it leaves minimal room for the dividend growth income investors are buying the stock for.
• Valuation risk from an elevated forward multiple. At 20.4x forward earnings versus a 16.0x five-year average, a re-rating toward its own history on $4.70-$4.85 of forward EPS implies $80-$85, or 12%-18% downside, before any fundamental deterioration.
• Arizona data-center cost-allocation politics. The new pledge framework pushes grid infrastructure costs onto large customers; if that slows the industrial pipeline or triggers a political fight with the ACC, it removes the structural growth premium the stock currently commands.

PNW is a genuinely good franchise priced as a very good one. Arizona is the best growth utility jurisdiction in the country, and the accelerating top line - +11.4% revenue in Q1 2026, +7.1% in Q2 - is real evidence of it. But the earnings engine is not yet participating: FY2026 EPS is guided roughly 8% below FY2025's $5.05, operating income was flat YoY in Q2 2026, free cash flow is running about -$1.4B annualized, and the payout ratio is near 75%. Paying 20.4x forward earnings against a 16.0x five-year average for a company whose current-year EPS is falling means you are prepaying for the 2027-2029 rate-base recovery, and you are doing it with the stock below all three key moving averages and the deterministic screen scoring it in weak-fundamentals territory. The Arizona growth story is a 2027-and-beyond story; the interest and depreciation drag is a 2026 reality. I would not own this at $96.11 - I would want either the multiple reset (the $85-$88 area, near the 52-week low and roughly 17.5-18x normalized earnings) or a concrete constructive ACC outcome that de-risks the earnings baseline. Note this is analysis, not personalized financial advice.

I used a justified forward P/E as the primary method, blended with two cross-checks. Primary: 18.5x on roughly $4.85 of next-twelve-month EPS (a blend of the $4.65 FY2026 guidance midpoint and the FMP next-FY estimate of $4.716, rolled forward for the strong summer quarters) = ~$90, where the 18.5x is a modest premium to PNW's own 16.0x five-year average to reflect Arizona's above-average load growth, offset by the ~75% payout ratio and the 8.7% ROE running below the allowed band. Cross-check one: the $3.47 dividend at a 3.6%-3.7% required yield implies $94-$96. Cross-check two: 1.65x book value on $58.05 of book value per share ($7.035B equity / ~121.2M shares) implies ~$96. Weighting toward the earnings multiple (45%) given the current-year EPS decline, with the dividend (30%) and book (25%) cross-checks, produces approximately $93 - roughly 3% below the 2026-09-13 price of $96.11 and well below the $106.86 analyst consensus, because I am not willing to underwrite a 20x+ multiple on earnings that are currently going backwards.